Minnesota Legislature
HF 5103
as introduced - 93rd Legislature (2023 - 2024) Posted on 03/21/2024 02:31pm
1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19
A bill for an act
relating to commerce; modifying cannabis labeling requirements; amending
Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
Section 1.
Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6, is amended
to read:
Subd. 6.
Additional information.
(a) A cannabis microbusiness, cannabis mezzobusiness,
cannabis retailer, medical cannabis retailer, or medical cannabis combination business must
provide customers and patients with the following information:
(1) factual information new text begin specified by the office new text end about impairment effects and the expected
timing of impairment effects, side effects, adverse effects, new text begin risks to mental health, risks to
the developing brain, contraindications during pregnancy and breast feeding, addiction
potential, medication interactions, interactions with preexisting medical conditions, new text end and
new text begin other new text end health risks new text begin supported by science new text end of cannabis flower, cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products;
(2) a statement new text begin specified by the office new text end that customers and patients must not operate a
motor vehicle or heavy machinery deleted text begin while under the influence of cannabis flower, cannabis
products, lower-potency hemp edibles, and hemp-derived consumer productsdeleted text end new text begin for eight hours
after consuming edible THC-containing products or for four hours after smoking or vaping
THC-containing productsnew text end ;
(3) resources new text begin specified by the office that new text end customers and patients may consult to answer
questions about cannabis flower, cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products, and any side effects and adverse effects;
(4) contact information for the poison control center and a safety hotline or website for
customers to report and obtain advice about side effects and adverse effects of cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products;
(5) substance use disorder treatment options; and
(6) any other information specified by the office.
(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical
cannabis retailer may include the information described in paragraph (a) on the label affixed
to the packaging or container of cannabis flower, cannabis products, lower-potency hemp
edibles, and hemp-derived consumer products bydeleted text begin :
deleted text end
deleted text begin
(1) posting the information in the premises of the cannabis microbusiness, cannabis
mezzobusiness, cannabis retailer, medical cannabis retailer, or medical cannabis combination
business; or
deleted text end
deleted text begin (2)deleted text end providing the information on a separate document or pamphlet provided to customers
or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency
hemp edible, or a hemp-derived consumer product.